Sho, Masayuki
Nara Medical University,
Japan
2025 Rank: 271529
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Surgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1500 out of 141119 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 271529 | 240293 |
| Total Cites | 865 | 977 |
| H-index | 14 | 15 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 25 | 35 |
| Number of Single+First+Last Authored Papers | 116 | 116 |
| Total Cites to Single+First+Last Authored Papers | 161 | 184 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 761 | 826 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.18 |
| Self-Citation Percentage |
11.46%
|
|
Sho, Masayuki
Nara Medical University,
Japan
2024 Rank: 269804
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Surgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1630 out of 132828 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 269804 | 240478 |
| Total Cites | 767 | 893 |
| H-index | 12 | 13 |
| Hm-index | 3 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 35 | 49 |
| Number of Single+First+Last Authored Papers | 101 | 101 |
| Total Cites to Single+First+Last Authored Papers | 127 | 149 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 686 | 745 |
| Ratio of Total Citations to Distinct Citing Papers | 1.12 | 1.20 |
| Self-Citation Percentage |
14.11%
|
|
Sho, Masayuki
Nara Medical University,
Japan
2023 Rank: 212195
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Surgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1301 out of 125272 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 212195 | 212688 |
| Total Cites | 876 | 980 |
| H-index | 13 | 14 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 26 | 26 |
| Total Cites to Single+First Authored Papers | 46 | 49 |
| Number of Single+First+Last Authored Papers | 89 | 89 |
| Total Cites to Single+First+Last Authored Papers | 142 | 155 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 771 | 837 |
| Ratio of Total Citations to Distinct Citing Papers | 1.14 | 1.17 |
| Self-Citation Percentage |
10.61%
|
|
Sho, Masayuki
Nara Medical University,
Japan
2020 Rank: 233650
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Surgery
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 1513 out of 80940 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 233650 | 243184 |
| Total Cites | 813 | 924 |
| H-index | 13 | 13 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 56 | 66 |
| Number of Single+First+Last Authored Papers | 46 | 46 |
| Total Cites to Single+First+Last Authored Papers | 97 | 111 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 722 | 785 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.18 |
| Self-Citation Percentage |
12.01%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.